Thursday, August 28, 2014 6:31:25 AM
On the negative side, the pps remains below the 50 day MA.
For those who keep wondering about my opinion on the company, I am sure that it has horrible management, however it has one excellent product in MANF, which if it does not actually make it to the clinic will most certainly attract investment dollars. IF they complete the p 16 deal, then they will have two interesting compounds. NOW, if I were Dr A, I would make a deal with Pharma and not a small biotech with no money like AMBS, so we will have to see about that. However, if they do not finalize P16 they have MANF.
Within that framework, the PPS will go up and down, and so, when I am materially incorrect about my predictions about the compounds or the pps then let me know, but so far, I've hit every one of the marks. And that is what it is all about.
The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM